SIGA TECHNOLOGIES INC (SIGA) Stock News

Stay updated with the stocks that are on the move in today's after-hours session.

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Japan Approves SIGA Technologies Antiviral As First For Smallpox, Mpox

Japan approves SIGA's TEPOXX for smallpox, mpox, and cowpox, expanding antiviral availability for orthopoxviruses with proven safety and efficacy.

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpoxJapan Biotechno...

Arm Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced

Interim analysis shows that tecovirimat did not improve time to lesion resolution compared to placebo in adults with mild to moderate clade II mpoxStudy...

SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced...

Bragar Eagel & Squire, P.C. Is Investigating CSX, Stride, and SIGA and Encourages Investors to Contact the Firm

SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in...

SIGA Announces Agreement to Supply TPOXX® in Morocco

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) --  SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in...

SIGA ALERT: Bragar Eagel & Squire, P.C. is Investigating SIGA Technologies, Inc. on Behalf of SIGA Stockholders and Encourages Investors to Contact the Firm

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against SIGA Technologies, Inc. (SIGA)

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®

NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in...

Immunome Stock Sees RS Rating Jump To 91

Immunome stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 88 to 91.

GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?

GeoVax Labs has seen its shares rise enormously over the past few days after an announcement from the World Health Organization relevant to one of its drugs.

PTC Therapeutics Stock Earns RS Rating Upgrade To 83

The Relative Strength (RS) Rating for PTC Therapeutics stock climbed into a new percentile Monday, with a rise from 80 to 83.